Showing results (11-20 of 112) with videos related to
Sort By:
Pageof 12
Seminars in Oncology|April 1, 1995
Oral vinorelbine (Navelbine) in the treatment of advanced breast cancerE P Winer, L Chu, D V SpicerHellenika Stomatologika Chronika. Hellenic Stomatological Annals|July 1, 1989
[Indications and contraindications of the administration of antibiotics in oral and maxillofacial surgery]E Stavrou, S Vassiliou, S KamberosTo Helleniko Periodiko Gia Stomatike & Gnathoprosopike Cheirourgike|March 1, 1989
[Fracture of the styloid process]E Stavrou, C Martis, S VassiliouESMO Open|June 18, 2025
Outcomes with trastuzumab deruxtecan by biomarker status, line of treatment and prior receipt of sacituzumab govitecan in a large real-world database of patients with metastatic breast cancerP Tarantino, D Lee, J Foldi, et al.Breast Cancer Research and Treatment|May 7, 2013
A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancerN U Lin, D S Seah, R Gelman, et al.Journal of the National Cancer Institute. Monographs|January 5, 2002
Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancerA H Partridge, H J Burstein, E P WinerSeminars in Oncology|August 11, 2001
New cytotoxic agents and schedules for advanced breast cancerH J Burstein, C A Bunnell, E P WinerJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Why women gain weight with adjuvant chemotherapy for breast cancerW Demark-Wahnefried, E P Winer, B K RimerThe American Journal of Medicine|April 1, 1997
A review of hereditary breast cancer: from screening to risk factor modificationM A Warmuth, L M Sutton, E P WinerBreast Disease|February 3, 2005
Quality of life issues among women undergoing high-dose chemotherapy for breast cancerA H Partridge, C A Bunnell, E P WinerPageof 12